ST. LOUIS, Sept. 19 /PRNewswire/ -- Mallinckrodt Inc. (NYSE: MKG)
shareholders have approved adoption of a merger agreement with subsidiaries of
Tyco International Ltd. The action occurred at a special meeting of
Mallinckrodt shareholders today in New York.
Approval of the agreement by Mallinckrodt shareholders is one of several
approvals required before the deal can be closed. This transaction remains
subject to approval by United States and certain foreign regulatory agencies.
While it is difficult to predict a timetable, the companies are working to
close the transaction in October.
About Mallinckrodt
Mallinckrodt Inc. is a global manufacturer and marketer of specialty
medical products designed to sustain breathing, diagnose disease and relieve
pain. Named one of America's most admired medical products and equipment
companies by Fortune magazine, Mallinckrodt does business in more than 100
countries. In fiscal 2000, combined net sales were $2.7 billion for
Mallinckrodt's respiratory, imaging and pharmaceutical product lines. Based
in St. Louis, Mo., Mallinckrodt's website address is http://www.mallinckrodt.com .
SOURCE Mallinckrodt Inc.
 back to top
Related links:
http://www.mallinckrodt.com
Company News On-Call:
http://www.prnewswire.com/comp/440950.html or fax,
800-758-5804, ext. 440950
CONTACT:
Media, Barbara Abbett of Mallinckrodt Inc,
314-654-5230, or barbara.abbett@mkg.com; or Investors, Robert
Martsching, 314-654-3190, or Invest@mkg.com
|
